The Supreme Court Case That Could Slow Generic Drugs

AI Briefing

• – Supreme Court rules that generic versions of certain brand-name medicines can't be approved until a full study of their safety is conducted.
• – Decision could slow the introduction of generic versions of the painkiller Advil and the cholesterol-lowering medication Vytorin.
• – The ruling could also have implications for the development and approval of generic versions of other branded medicines.